MSTR® McLoughlin Scar Tissue Release
What is A Scar?
A scar is an area of fibrous tissue that replaces normal skin after it has been punctured either by accident or through surgery. The scar is a result of the body’s wound repair process. Scarring is a way of protecting the body from further injury and infection however this tissue is not the same as normal skin and is often dry and fibrous making it less flexible
What Impact Can it have on your body?
The fibrous tissue of the scar can look unpleasant, feel uncomfortable and upset us emotionally due to the traumatic events that created the scar.
Scars have a significant impact on the body and are often the root cause of non-resolving aches and pains. Scars can cause the following:
Restriction in the Fascia
Reduction in blood and lymph flow
Weaken muscular strength
Reduce the flow of energy
Inhibit joint movement
How can MSTR® help you?
MSTR is an innovative, pain-free, natural method of helping you with your scars. Through gentle, finger-tip pressure applied to the area of the scar we encourage the body to free the restrictions in the area, creating increase blood flow and improving joint movement
Press Release from MSTR® - Scar Study
I am delighted to announce the results of the preliminary study into the effects of McLoughlin Scar Tissue Release® (MSTR®) on Caesarean Section scars.
The research project was conducted at The Newcastle Clinic, Newcastle, UK on June 15th, 2019 with Consultant Radiologist Dr Peddada Raju.
A General Electric (GE) Soniq S8 ultrasound scanner was used to conduct the test on three test subjects with C-section scars
Each subjects was pre-scanned and images recorded including:
• Size and depth of scar tissue.
• The amount of vascularity both surrounding and within the scar was also imaged.
MSTR® work was then applied for a total of 15 minutes per subject, as a single treatment.
Immediately after MSTR® treatment each subject underwent a post-treatment ultrasound scan conducted by Dr Raju.
All three subjects were shown to have decreased scar tissue in the post treatment scan. One example of improvement was of a scar that was initially measured at 31.5mm pre treatment. The scar was re-measured at just 18.1mm post treatment.
Another example was that of a longitudinal scar reducing in size from 22.7mm pre-treatment to just 10.4mm post-treatment.
An increase in vascularity was noted not only in the surrounding tissue but also actually through the scar. Interestingly it should be noted that NO vascularity was present in the pre-scan of the same area.
This confirms what has always been stated:
MSTR® helps open the densely bound collagen fibres that make up scar tissue to allow increased blood flow into the area once again.
This preliminary success has now kick-started a larger study that will be undertaken at ‘The Newcastle’ later in 2019.
You can read more about the MSTR® Research Project here:
This initial research project, demonstrating evidence-based outcomes of the MSTR® method of scar tissue treatment, means you can have even more confidence in MSTR® work.